Reactogenicity, safety and antibody response, after one and two doses of mRNA-1273 in seronegative and seropositive healthcare workers

por Tré-Hardy, Marie, Cupaiolo, Roberto, Papleux, Emmanuelle, Wilmet, Alain, Horeanga, Alexandra, Antoine-Moussiaux, Thomas, Della Vecchia, Andrea, Beukinga, Ingrid, Vekemans, Marc, Blairon, Laurent
Publicado 2021

Immunogenicity of mRNA-1273 COVID vaccine after 6 months surveillance in health care workers; a third dose is necessary

por Tré-Hardy, Marie, Cupaiolo, Roberto, Wilmet, Alain, Antoine-Moussiaux, Thomas, Della Vecchia, Andrea, Horeanga, Alexandra, Papleux, Emmanuelle, Vekemans, Marc, Beukinga, Ingrid, Blairon, Laurent
Publicado 2021

Role of the Bronchoalveolar Lavage in Noncritically Ill Patients during the SARS-CoV-2 Epidemic

por Taton, Olivier, Papleux, Emmanuelle, Bondue, Benjamin, Knoop, Christiane, Van Laethem, Sébastien, Bauler, Alain, Martiny, Delphine, Montesinos, Isabel, Delforge, Marie-Luce, Elmaouhab, Kahina, Leduc, Dimitri
Publicado 2020

Assessment 2 months after the administration of a 3rd dose mRNA: a new variant-adapted vaccine is expected

por Tré-Hardy, Marie, Cupaiolo, Roberto, Wilmet, Alain, Antoine-Moussiaux, Thomas, Coman-Vlagea, Nicoleta, Della Vecchia, Andrea, Horeanga, Alexandra, Papleux, Emmanuelle, Vekemans, Marc, Beukinga, Ingrid, Blairon, Laurent
Publicado 2022

Azithromycin for treatment of hospitalised COVID-19 patients: a randomised, multicentre, open-label clinical trial (DAWn-AZITHRO)

por Gyselinck, Iwein, Liesenborghs, Laurens, Belmans, Ann, Engelen, Matthias M., Betrains, Albrecht, Van Thillo, Quentin, Nguyen, Pham Anh Hong, Goeminne, Pieter, Soenen, Ann-Catherine, De Maeyer, Nikolaas, Pilette, Charles, Papleux, Emmanuelle, Vanderhelst, Eef, Derweduwen, Aurélie, Alexander, Patrick, Bouckaert, Bernard, Martinot, Jean-Benoît, Decoster, Lynn, Vandeurzen, Kurt, Schildermans, Rob, Verhamme, Peter, Janssens, Wim, Vos, Robin
Publicado 2022